Boehringer Ingelheim advances obesity drug candidate with up to 19% weight loss in mid-stage trial

2 years ago 25

German pharmaceutical company Boehringer Ingelheim revealed its intention to launch three advanced-stage investigations into its promising obesity drug candidate.

1. Homepage
2. National News
3. Boehringer Ingelheim advances obesity drug candidate with up to 19% weight loss in mid-stage trial